ReviewHuman vaccines & immunotherapeutics2026
Tebentafusp (IMCgp100), a first in class immune-mobilizing monoclonal T-cell receptors against cancer (ImmTAC) for HLA-A*02:01 positive uveal melanoma: Product review.
Jonathan E Cohen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.